Skip to main content
Premium Trial:

Request an Annual Quote

NextGen Sciences Spins Off Automation and Software Business

NEW YORK (GenomeWeb News) – NextGen Sciences has spun off its “gene to protein’ automation and software business to a management-led buyout group called eXeTek Ltd.
Ann Arbor, Mich.-based NextGen said that the divestiture is in line with its previously announced plans to either sell or wind down the automation and software business and focus its resources on growing its protein biomarker services business. The firm’s biomarker discovery and assay development service, called biomarkerexpress, was launched in November 2007.
The firm said that eXeTek will continue to support the existing installed base of automation and software products. As part of the deal, NextGen exclusively licensed the expressionfactory, expressworkstation, and orchestratorIMS software to eXeTek. NextGen also acquired a 24 percent stake in the startup and will receive a 5 percent royalty on sales of the products for three years.
Further terms of the deal were not disclosed.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.